Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 4
2006 9
2007 8
2008 7
2009 11
2010 8
2011 12
2012 18
2013 37
2014 23
2015 25
2016 27
2017 19
2018 14
2019 15
2020 48
2021 56
2022 42
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

367 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 reinfection and COVID-19 severity.
Nguyen NN, Houhamdi L, Hoang VT, Delerce J, Delorme L, Colson P, Brouqui P, Fournier PE, Raoult D, Gautret P. Nguyen NN, et al. Among authors: colson p. Emerg Microbes Infect. 2022 Dec;11(1):894-901. doi: 10.1080/22221751.2022.2052358. Emerg Microbes Infect. 2022. PMID: 35264078 Free PMC article.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Gautret P, et al. Among authors: colson p. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. PMID: 32205204 Free PMC article. Clinical Trial.
COVID-19 re-infection.
Brouqui P, Colson P, Melenotte C, Houhamdi L, Bedotto M, Devaux C, Gautret P, Million M, Parola P, Stoupan D, La Scola B, Lagier JC, Raoult D. Brouqui P, et al. Among authors: colson p. Eur J Clin Invest. 2021 May;51(5):e13537. doi: 10.1111/eci.13537. Epub 2021 Mar 17. Eur J Clin Invest. 2021. PMID: 33675046 Free PMC article. No abstract available.
Marseilleviruses: An Update in 2021.
Sahmi-Bounsiar D, Rolland C, Aherfi S, Boudjemaa H, Levasseur A, La Scola B, Colson P. Sahmi-Bounsiar D, et al. Among authors: colson p. Front Microbiol. 2021 Jun 2;12:648731. doi: 10.3389/fmicb.2021.648731. eCollection 2021. Front Microbiol. 2021. PMID: 34149639 Free PMC article. Review.
Recent data on hepatitis E.
Colson P, Decoster C. Colson P, et al. Curr Opin Infect Dis. 2019 Oct;32(5):475-481. doi: 10.1097/QCO.0000000000000590. Curr Opin Infect Dis. 2019. PMID: 31361659 Review.
Rhizomal Reclassification of Living Organisms.
Ibrahim A, Colson P, Merhej V, Zgheib R, Maatouk M, Naud S, Bittar F, Raoult D. Ibrahim A, et al. Among authors: colson p. Int J Mol Sci. 2021 May 26;22(11):5643. doi: 10.3390/ijms22115643. Int J Mol Sci. 2021. PMID: 34073251 Free PMC article. Review.
Antibiotic resistance surveillance systems: A review.
Diallo OO, Baron SA, Abat C, Colson P, Chaudet H, Rolain JM. Diallo OO, et al. Among authors: colson p. J Glob Antimicrob Resist. 2020 Dec;23:430-438. doi: 10.1016/j.jgar.2020.10.009. Epub 2020 Nov 8. J Glob Antimicrob Resist. 2020. PMID: 33176216 Free article. Review.
Measles, the need for a paradigm shift.
Javelle E, Colson P, Parola P, Raoult D. Javelle E, et al. Among authors: colson p. Eur J Epidemiol. 2019 Oct;34(10):897-915. doi: 10.1007/s10654-019-00569-4. Epub 2019 Oct 17. Eur J Epidemiol. 2019. PMID: 31624970 Review.
Response.
Borentain P, Renard S, Colson P. Borentain P, et al. Among authors: colson p. Chest. 2016 Jul;150(1):258. doi: 10.1016/j.chest.2016.05.012. Chest. 2016. PMID: 27396789 No abstract available.
367 results